Prevalence of bacteriuria and treatment outcomes in patients with symptomatic benign prostatic hyperplasia: a prospective observational study
Authors:
- Niroj RamdamNRNiroj Ramdam
- Pawan Sapkota UpadhyaPUPawan Sapkota Upadhya
- Prajjwol Mbbs LuitelPLPrajjwol Mbbs Luitel
- Ishwor Mbbs ThapaliyaITIshwor Mbbs Thapaliya
- Sujan Mbbs PaudelSPSujan Mbbs Paudel
- Shiwangi KashyapSKShiwangi Kashyap
- Rikesh Jung KarkeeRKRikesh Jung Karkee
- Rakesh Kumar GuptaRGRakesh Kumar Gupta
Open Access
- 16 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (12) , 6997-7001
Abstract
Introduction: The global incidence of benign prostatic hyperplasia (BPH) is rising, with bacterial causes of lower urinary tract symptoms (LUTS) being a common factor contributing to complications in these patients. Aim: To identify the prevalence of bacteriuria and treatment response in patients with symptomatic BPH. Materials and methods: This 1-year prospective study included all patients presenting with LUTS due to BPH who met the inclusion criteria. Urine samples were collected and analyzed for microscopy, culture, and sensitivity following standard protocols. Bacterial growth in urine specimens and International Prostate Symptom Score (IPSS) of LUTS were recorded before and after antibiotic therapy. Results: A total of 131 patients with symptomatic BPH were studied. Escherichia coli (47.6%) was the most commonly isolated bacteria, followed by Klebsiella pneumoniae and Pseudomonas species. E. coli and Klebsiella showed the highest sensitivity to nitrofurantoin. After 1 week of antibiotic therapy, 69% of patients had sterile urine cultures, while 31% remained E. coli positive. Significant improvement in IPSS scores was observed after 1 week of therapy ( P P =0.854). Conclusion: Bacteriuria is a common finding in patients with symptomatic BPH in our setting. Escherichia coli and Klebsiella pneumoniae were the most frequently isolated organisms, with sensitivity to nitrofurantoin and cefixime. A week of antibiotic therapy significantly reduced IPSS scores but did not reduce bacteriuria.Keywords
This publication has 15 references indexed in Scilit:
- STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgeryInternational Journal of Surgery, 2021
- Complicated urinary tract infection in patients with benign prostatic hyperplasiaJournal of Infection and Chemotherapy, 2021
- Urinary Tract Infections among Bladder Outlet Obstruction Patients in Accra, Ghana: Aetiology, Antibiotic Resistance, and Risk FactorsDiseases, 2018
- Bacteriology of urine specimens obtained from men with symptomatic benign prostatic hyperplasiaNigerian Journal of Surgery, 2016
- Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on TadalafilThe World Journal of Men's Health, 2013
- Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladderWorld Journal of Urology, 2011
- Urinary Infection Before and After Prostatectomy2010
- Pathophysiology of lower urinary tract symptoms in the aging male population.2005
- Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trialsArchives of Disease in Childhood, 2002
- Prevalence of Lower Urinary Tract Symptoms in Korean Men in a Community-Based StudyEuropean Urology, 1998